Literature DB >> 36168391

Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern.

Peifang Sun1, Irene Ramos2,3, Camila H Coelho4, Alba Grifoni4, Corey A Balinsky1,5, Sindhu Vangeti2,3,6, Alison Tarke4, Nathaniel I Bloom4, Vihasi Jani1,5, Silvia J Jakubski5, David A Boulifard5, Elizabeth Cooper1, Carl W Goforth1,7, Jan Marayag1, Amethyst Marrone1, Edgar Nunez1, Lindsey White1,5, Chad K Porter1, Victor A Sugiharto1,5, Megan Schilling1, Avinash S Mahajan2, Charmagne Beckett1, Alessandro Sette4,8, Stuart C Sealfon2, Shane Crotty4,8, Andrew G Letizia1,9.   

Abstract

The ongoing evolution of SARS-CoV-2 requires monitoring the capability of immune responses to cross-recognize Variants of Concern (VOC). In this cross-sectional study, we examined serological and cell-mediated immune memory to SARS-CoV-2 variants, including Omicron, among a cohort of 18-21-year-old Marines with a history of either asymptomatic or mild SARS-CoV-2 infection 6 to 14 months earlier. Among the 210 participants in the study, 169 were unvaccinated while 41 received 2 doses of mRNA-based COVID-19 vaccines. Vaccination of previously infected participants strongly boosted neutralizing and binding activity and memory B and T cell responses including the recognition of Omicron, compared to infected but unvaccinated participants. Additionally, no measurable differences were observed in immune memory in healthy young adults with previous symptomatic or asymptomatic infections, for ancestral or variant strains. These results provide mechanistic immunological insights into population-based differences observed in immunity against Omicron and other variants among individuals with different clinical histories.

Entities:  

Keywords:  Biological sciences; immunology; microbiology

Year:  2022        PMID: 36168391      PMCID: PMC9502440          DOI: 10.1016/j.isci.2022.105202

Source DB:  PubMed          Journal:  iScience        ISSN: 2589-0042


  52 in total

1.  Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years.

Authors:  Erez Bar-Haim; Noa Eliakim-Raz; Amos Stemmer; Hila Cohen; Uri Elia; Asaf Ness; Muhammad Awwad; Nassem Ghantous; Neta Moskovits; Shahar Rotem; Salomon M Stemmer
Journal:  J Clin Med       Date:  2022-05-08       Impact factor: 4.964

2.  Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.

Authors:  Rishi R Goel; Sokratis A Apostolidis; Mark M Painter; Divij Mathew; Ajinkya Pattekar; Oliva Kuthuru; Sigrid Gouma; Philip Hicks; Wenzhao Meng; Aaron M Rosenfeld; Sarah Dysinger; Kendall A Lundgreen; Leticia Kuri-Cervantes; Sharon Adamski; Amanda Hicks; Scott Korte; Derek A Oldridge; Amy E Baxter; Josephine R Giles; Madison E Weirick; Christopher M McAllister; Jeanette Dougherty; Sherea Long; Kurt D'Andrea; Jacob T Hamilton; Michael R Betts; Eline T Luning Prak; Paul Bates; Scott E Hensley; Allison R Greenplate; E John Wherry
Journal:  Sci Immunol       Date:  2021-04-15

3.  Age groups that sustain resurging COVID-19 epidemics in the United States.

Authors:  Mélodie Monod; Alexandra Blenkinsop; Xiaoyue Xi; Daniel Hebert; Sivan Bershan; Simon Tietze; Oliver Ratmann; Marc Baguelin; Valerie C Bradley; Yu Chen; Helen Coupland; Sarah Filippi; Jonathan Ish-Horowicz; Martin McManus; Thomas Mellan; Axel Gandy; Michael Hutchinson; H Juliette T Unwin; Sabine L van Elsland; Michaela A C Vollmer; Sebastian Weber; Harrison Zhu; Anne Bezancon; Neil M Ferguson; Swapnil Mishra; Seth Flaxman; Samir Bhatt
Journal:  Science       Date:  2021-02-02       Impact factor: 47.728

4.  SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.

Authors:  Dhiraj Mannar; James W Saville; Xing Zhu; Shanti S Srivastava; Alison M Berezuk; Katharine S Tuttle; Ana Citlali Marquez; Inna Sekirov; Sriram Subramaniam
Journal:  Science       Date:  2022-01-20       Impact factor: 47.728

5.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Authors:  Takuya Sekine; André Perez-Potti; Olga Rivera-Ballesteros; Kristoffer Strålin; Jean-Baptiste Gorin; Annika Olsson; Sian Llewellyn-Lacey; Habiba Kamal; Gordana Bogdanovic; Sandra Muschiol; David J Wullimann; Tobias Kammann; Johanna Emgård; Tiphaine Parrot; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Jan-Inge Henter; Anders Sönnerborg; Tobias Allander; Jan Albert; Morten Nielsen; Jonas Klingström; Sara Gredmark-Russ; Niklas K Björkström; Johan K Sandberg; David A Price; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Cell       Date:  2020-08-14       Impact factor: 41.582

6.  SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.

Authors:  Andrew G Letizia; Yongchao Ge; Sindhu Vangeti; Carl Goforth; Dawn L Weir; Natalia A Kuzmina; Corey A Balinsky; Hua Wei Chen; Dan Ewing; Alessandra Soares-Schanoski; Mary-Catherine George; William D Graham; Franca Jones; Preeti Bharaj; Rhonda A Lizewski; Stephen E Lizewski; Jan Marayag; Nada Marjanovic; Clare M Miller; Sagie Mofsowitz; Venugopalan D Nair; Edgar Nunez; Danielle M Parent; Chad K Porter; Ernesto Santa Ana; Megan Schilling; Daniel Stadlbauer; Victor A Sugiharto; Michael Termini; Peifang Sun; Russell P Tracy; Florian Krammer; Alexander Bukreyev; Irene Ramos; Stuart C Sealfon
Journal:  Lancet Respir Med       Date:  2021-04-15       Impact factor: 30.700

7.  SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.

Authors:  Alison Tarke; Camila H Coelho; Zeli Zhang; Jennifer M Dan; Esther Dawen Yu; Nils Methot; Nathaniel I Bloom; Benjamin Goodwin; Elizabeth Phillips; Simon Mallal; John Sidney; Gilberto Filaci; Daniela Weiskopf; Ricardo da Silva Antunes; Shane Crotty; Alba Grifoni; Alessandro Sette
Journal:  Cell       Date:  2022-01-24       Impact factor: 41.582

8.  SARS-CoV-2: from herd immunity to hybrid immunity.

Authors:  David Goldblatt
Journal:  Nat Rev Immunol       Date:  2022-06       Impact factor: 108.555

9.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals.

Authors:  Alison Tarke; John Sidney; Nils Methot; Esther Dawen Yu; Yun Zhang; Jennifer M Dan; Benjamin Goodwin; Paul Rubiro; Aaron Sutherland; Eric Wang; April Frazier; Sydney I Ramirez; Stephen A Rawlings; Davey M Smith; Ricardo da Silva Antunes; Bjoern Peters; Richard H Scheuermann; Daniela Weiskopf; Shane Crotty; Alba Grifoni; Alessandro Sette
Journal:  Cell Rep Med       Date:  2021-07-02

10.  An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status.

Authors:  Sheila F Lumley; Gillian Rodger; Bede Constantinides; Nicholas Sanderson; Kevin K Chau; Teresa L Street; Denise O'Donnell; Alison Howarth; Stephanie B Hatch; Brian D Marsden; Stuart Cox; Tim James; Fiona Warren; Liam J Peck; Thomas G Ritter; Zoe de Toledo; Laura Warren; David Axten; Richard J Cornall; E Yvonne Jones; David I Stuart; Gavin Screaton; Daniel Ebner; Sarah Hoosdally; Meera Chand; Derrick W Crook; Anne-Marie O'Donnell; Christopher P Conlon; Koen B Pouwels; A Sarah Walker; Tim E A Peto; Susan Hopkins; Timothy M Walker; Nicole E Stoesser; Philippa C Matthews; Katie Jeffery; David W Eyre
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.